Joseph Horrigan
Hoofd Techniek/Wetenschap/O&O bij AMO Pharma Ltd.
Profiel
Joseph Horrigan is currently an Associate Professor at The University of North Carolina at Charlotte and the Chief Medical Officer at AMO Pharma Ltd.
He previously worked as the VP-Clinical Development & Medical Affairs at Neuren Pharmaceuticals Ltd.
He earned a doctorate degree from the University of Rochester.
Actieve functies van Joseph Horrigan
| Bedrijven | Functie | Begin |
|---|---|---|
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Joseph Horrigan
| Bedrijven | Functie | Einde |
|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Joseph Horrigan
| Rochester Christian University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
